Enanta Pharmaceuticals | 4:持股變動聲明-高管 Kowalsky Matthew Paul
Enanta Pharmaceuticals | 3:首次持股聲明-高管 Kowalsky Matthew Paul
Enanta Pharmaceuticals | 4:持股變動聲明-董事 Vance Terry
Enanta Pharmaceuticals | 4:持股變動聲明-董事 Russell Lesley
Enanta Pharmaceuticals | 4:持股變動聲明-董事 Peterson Kristine
Enanta Pharmaceuticals | 4:持股變動聲明-董事 Hata Yujiro S
Enanta Pharmaceuticals | 4:持股變動聲明-董事 FOLETTA MARK G
Enanta Pharmaceuticals | 4:持股變動聲明-董事 CARTER BRUCE L A
Enanta Pharmaceuticals | 4:持股變動聲明-高管 Gardiner Nathaniel S.
Enanta Pharmaceuticals | 4:持股變動聲明-高管 Luu Brendan
Enanta Pharmaceuticals | 4:持股變動聲明-高管 Kieffer Tara Lynn
Enanta Pharmaceuticals | 4:持股變動聲明-高管 Gardiner Nathaniel S.
Enanta Pharmaceuticals | 4:持股變動聲明-高管 Rottinghaus Scott T.
Enanta Pharmaceuticals | 4:持股變動聲明-高管 Or Yat Sun
Enanta Pharmaceuticals | 4:持股變動聲明-高管 MELLETT PAUL J
Enanta Pharmaceuticals | 4:持股變動聲明-高管 Luly Jay R.
Enanta Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-Armistice Capital, LLC(9.80%),Steven Boyd(9.80%)
Enanta Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-The Vanguard Group(8.52%)
Enanta Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-Joshua J. Dapice(9.6%),Philip D. Dreyfuss(9.6%)等
Enanta Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-BlackRock, Inc.(9.2%)
暫無數據